Parving, Hans-Henrik.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points

Parving, Hans-Henrik, Andersen, Steen, Jacobsen, Peter, Christensen, Per K, Rossing, Kasper, Hovind, Peter, Rossing, Peter, Tarnow, Lise

Journal:

Seminars in Nephrology

Year:

2004

Language:

english

File:

PDF, 134 KB

english, 2004

2

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Zhang, Zhonxin, Shahinfar, Shahnaz, Brenner, Barry M., Cooper, Mark E., de Zeeuw, Dick, Keane, William F., Mitch, William E., Parving, Hans-Henrik, Remuzzi, Giuseppe, Snapinn, Steven M.

Journal:

Boston Medical and Surgical Journal

Year:

2001

Language:

english

File:

PDF, 135 KB

english, 2001

3

Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes

Gæde, Peter, Vedel, Pernille, Larsen, Nicolai, Jensen, Gunnar V.H., Parving, Hans-Henrik, Pedersen, Oluf

Journal:

Boston Medical and Surgical Journal

Year:

2003

Language:

english

File:

PDF, 127 KB

english, 2003

4

Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes

Gæde, Peter, Lund-Andersen, Henrik, Parving, Hans-Henrik, Pedersen, Oluf

Journal:

Boston Medical and Surgical Journal

Year:

2008

Language:

english

File:

PDF, 309 KB

english, 2008

5

Beneficial impact of spironolactone in diabetic nephropathy

Schjoedt, Katrine Jordan, Rossing, Kasper, Juhl, Tina Ragnholm, Boomsma, Frans, Rossing, Peter, Tarnow, Lise, Parving, Hans-Henrik

Journal:

Kidney International

Year:

2005

Language:

english

File:

PDF, 133 KB

english, 2005

6

The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes

Parving, Hans-Henrik, Lehnert, Hendrik, Bröchner-Mortensen, Jens, Gomis, Ramon, Andersen, Steen, Arner, Peter

Journal:

Boston Medical and Surgical Journal

Year:

2001

Language:

english

File:

PDF, 124 KB

english, 2001

7

Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy

Michael Larse, Eva Hommel, Hans-Henrik Parving, Henrik Lund-Andersen

Journal:

Graefe's Archive for Clinical and Experimental Ophthalmology

Year:

1990

Language:

english

File:

PDF, 605 KB

english, 1990

8

Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Versus Atorvastatin in Patients With Hypercholesterolemia and the Metabolic Syndrome (from the VYMET Study)

Jennifer G. Robinson, Christie M. Ballantyne, Scott M. Grundy, Willa A. Hsueh, Hans-Henrik Parving, Jeffrey B. Rosen, Adeniyi J. Adewale, Adam B. Polis, Joanne E. Tomassini, Andrew M. Tershakovec

Journal:

The American Journal of Cardiology

Year:

2009

Language:

english

File:

PDF, 269 KB

english, 2009

9

Association Between Cardiac Biomarkers and the Development of ESRD in Patients With Type 2 Diabetes Mellitus, Anemia, and CKD

Akshay S. Desai, Robert Toto, Petr Jarolim, Hajime Uno, Kai-Uwe Eckardt, Reshma Kewalramani, Andrew S. Levey, Eldrin F. Lewis, John J.V. McMurray, Hans-Henrik Parving, Scott D. Solomon, Marc A. Pfeffe

Journal:

American Journal of Kidney Diseases

Year:

2011

Language:

english

File:

PDF, 1.61 MB

english, 2011

10

Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease

T.-Christian H. Mix, Robert M. Brenner, Mark E. Cooper, Dick de Zeeuw, Peter Ivanovich, Andrew S. Levey, Janet B. McGill, John J.V. McMurray, Patrick S. Parfrey, Hans-Henrik Parving, Brian J.G. Pereir

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 181 KB

english, 2005

11

Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)

John J.V. McMurray, Hajime Uno, Petr Jarolim, Akshay S. Desai, Dick de Zeeuw, Kai-Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis, Janet B. McGill, Patrick Parfrey, Hans-Henrik Parving,

Journal:

American Heart Journal

Year:

2011

Language:

english

File:

PDF, 463 KB

english, 2011

12

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

Peter Gæde, Pernille Vedel, Hans-Henrik Parving, Oluf Pedersen

Journal:

Year:

1999

Language:

english

File:

PDF, 101 KB

english, 1999

13

Elevated Levels of High-Molecular-Weight Adiponectin in Type 1 Diabetes

Leth, Henrik, Andersen, Kristian K., Frystyk, Jan, Tarnow, Lise, Rossing, Peter, Parving, Hans-Henrik, Flyvbjerg, Allan

Journal:

Journal of Clinical Endocrinology & Metabolism

Year:

2008

Language:

english

File:

PDF, 192 KB

english, 2008

14

Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial

de Zeeuw, Dick, Anzalone, Deborah A, Cain, Valerie A, Cressman, Michael D, Heerspink, Hiddo J Lambers, Molitoris, Bruce A, Monyak, John T, Parving, Hans-Henrik, Remuzzi, Giuseppe, Sowers, James R, Vid

Journal:

The Lancet Diabetes & Endocrinology

Year:

2015

Language:

english

File:

PDF, 311 KB

english, 2015

15

The DIabetic REtinopathy Candesartan Trials (DIRECT) Programme: baseline characteristics.

Sjolie, Anne Katrin, Porta, Massimo, Parving, Hans-Henrik, Bilous, Rudy, Klein, Ronald

Journal:

Journal of Renin-Angiotensin-Aldosterone System

Year:

2005

Language:

english

File:

PDF, 121 KB

english, 2005

16

Urinary renin and angiotensinogen in type 2 diabetes

Persson, Frederik, Lu, Xifeng, Rossing, Peter, Garrelds, Ingrid M., Danser, A.H. Jan, Parving, Hans-Henrik

Journal:

Journal of Hypertension

Year:

2013

Language:

english

File:

PDF, 340 KB

english, 2013

17

Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy

Weldegiorgis, Misghina, de Zeeuw, Dick, Li, Liang, Parving, Hans-Henrik, Hou, Fan Fan, Remuzzi, Giuseppe, Greene, Tom, Heerspink, Hiddo J.L.

Journal:

American Journal of Kidney Diseases

Year:

2017

Language:

english

File:

PDF, 1.70 MB

english, 2017

18

Effect of Insulin Analogs on Frequency of Non–Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose—The HypoAna Trial

Agesen, Rikke Mette, Kristensen, Peter Lommer, Beck-Nielsen, Henning, Nørgaard, Kirsten, Perrild, Hans, Jensen, Tonny, Parving, Hans-Henrik, Thorsteinsson, Birger, Tarnow, Lise, Pedersen-Bjergaard, Ul

Journal:

Diabetes Technology & Therapeutics

Year:

2018

Language:

english

File:

PDF, 289 KB

english, 2018

19

Atrasentan in patients with diabetes and chronic kidney disease â Authors' reply

Heerspink, Hiddo J L, Parving, Hans-Henrik, de Zeeuw, Dick

Journal:

Lancet (London, England)

Year:

2020

Language:

english

File:

PDF, 42 KB

english, 2020

20

Cataract surgery on diabetic patients. A prospective evaluation of risk factors and complications

Per Flesner, Birgit Sander, Vibeke Henning, Hans-Henrik Parving, Morten Dornonville De La Cour, Henrik Lund-Andersen

Journal:

Acta Ophthalmologica (Blackwell)

Year:

2002

Language:

english

File:

PDF, 98 KB

english, 2002

21

Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria

STEHOUWER, COEN DA, GALL, MARI-ANNE, HOUGAARD, PHILIP, JAKOBS, CORNELIS, PARVING, HANS-HENRIK

Journal:

Kidney International

Year:

1999

Language:

english

File:

PDF, 212 KB

english, 1999

22

Low-protein diet and kidney function in insulin-dependent diabetic patients with diabetic nephropathy

HANSEN, HENRIK P., CHRISTENSEN, PER K., TAUBER-LASSEN, ELLIS, KLAUSEN, ANNALISE, JENSEN, BERIT R., PARVING, HANS-HENRIK

Journal:

Kidney International

Year:

1999

Language:

english

File:

PDF, 340 KB

english, 1999

23

Impaired autoregulation of the glomerular filtration rate in patients with nondiabetic nephropathies

Christensen, Per K., Hommel, Eva E., Clausen, Peter, Feldt-Rasmussen, Bo, Parving, Hans-Henrik

Journal:

Kidney International

Year:

1999

Language:

english

File:

PDF, 321 KB

english, 1999

24

Progression of diabetic nephropathy in normotensive type 1 diabetic patients

Jacobsen, Peter, Rossing, Kasper, Tarnow, Lise, Rossing, Peter, Mallet, Christine, Poirier, Odette, Cambien, Francois, Parving, Hans-Henrik

Journal:

Kidney International

Year:

1999

Language:

english

File:

PDF, 169 KB

english, 1999

25

Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy

Christensen, Per K., Larsen, Svend, Horn, Thomas, Olsen, Steen, Parving, Hans-Henrik

Journal:

Kidney International

Year:

2000

Language:

english

File:

PDF, 483 KB

english, 2000

26

Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy

Andersen, Steen, Tarnow, Lise, Rossing, Peter, Hansen, Birgitte V, Parving, Hans-Henrik

Journal:

Kidney International

Year:

2000

Language:

english

File:

PDF, 170 KB

english, 2000

27

Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy

Bos, Hendrik, Andersen, Steen, Rossing, Peter, De Zeeuw, Dick, Parving, Hans-Henrik, De Jong, Paul E., Navis, Gerjan

Journal:

Kidney International

Year:

2000

Language:

english

File:

PDF, 330 KB

english, 2000

28

Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy

Hovind, Peter, Tarnow, Lise, Oestergaard, Per B., Parving, Hans-Henrik

Journal:

Kidney International

Year:

2000

Language:

english

File:

PDF, 145 KB

english, 2000

29

Diabetic nephropathy: Prevention and treatment

Parving, Hans-Henrik

Journal:

Kidney International

Year:

2001

Language:

english

File:

PDF, 226 KB

english, 2001

30

Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively1

Hovind, Peter, Rossing, Peter, Tarnow, Lise, Smidt, Ulla M, Parving, Hans-Henrik

Journal:

Kidney International

Year:

2001

Language:

english

File:

PDF, 132 KB

english, 2001

31

Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients

Parving, Hans-Henrik, Hommel, Eva, Jensen, Berit Ruud, Hansen, Henrik Post

Journal:

Kidney International

Year:

2001

Language:

english

File:

PDF, 132 KB

english, 2001

32

Autoregulated glomerular filtration rate during candesartan treatment in hypertensive type 2 diabetic patients

Christensen, Per K., Lund, Soren, Parving, Hans-Henrik

Journal:

Kidney International

Year:

2001

Language:

english

File:

PDF, 110 KB

english, 2001

33

Progression of diabetic nephropathy

Hovind, Peter, Rossing, Peter, Tarnow, Lise, Smidt, Ulla M., Parving, Hans-Henrik

Journal:

Kidney International

Year:

2001

Language:

english

File:

PDF, 748 KB

english, 2001

34

Diurnal variations of glomerular filtration rate and albuminuria in diabetic nephropathy

Hansen, Henrik P., Hovind, Peter, Jensen, Berit R., Parving, Hans-Henrik

Journal:

Kidney International

Year:

2002

Language:

english

File:

PDF, 95 KB

english, 2002

35

Renoprotective effects of losartan in diabetic nephropathy: Interaction with ACE insertion/deletion genotype?

Andersen, Steen, Tarnow, Lise, Cambien, Francois, Rossing, Peter, Juhl, Tina R, Deinum, Jaap, Parving, Hans-Henrik

Journal:

Kidney International

Year:

2002

Language:

english

File:

PDF, 83 KB

english, 2002

36

Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy

Hansen, Henrik P, Tauber-Lassen, Ellis, Jensen, Berit R, Parving, Hans-Henrik

Journal:

Kidney International

Year:

2002

Language:

english

File:

PDF, 205 KB

english, 2002

37

Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy

Jacobsen, Peter, Andersen, Steen, Rossing, Kasper, Jensen, Berit R, Parving, Hans-Henrik

Journal:

Kidney International

Year:

2003

Language:

english

File:

PDF, 136 KB

english, 2003

38

Submaximal dose of trandolapril in the COOPERATE trial?

Jacobsen, Peter, Parving, Hans-Henrik

Journal:

Kidney International

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

39

Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria

Sten Andersen, Harald Mischak, Petra Zürbig, Hans-Henrik Parving, Peter Rossing

Journal:

Year:

2010

Language:

english

File:

PDF, 2.42 MB

english, 2010

40

TheCTGF-945GC polymorphism is not associated with plasma CTGF and does not predict nephropathy or outcome in type 1 diabetes

Amélie Dendooven, Tri Q Nguyen, Lodewijk Brosens, Dongxia Li, Lise Tarnow, Hans-Henrik Parving, Peter Rossing, Roel Goldschmeding

Journal:

Journal of Negative Results in BioMedicine

Year:

2011

Language:

english

File:

PDF, 211 KB

english, 2011

41

Functional annotations of diabetes nephropathy susceptibility loci through analysis of genome-wide renal gene expression in rat models of diabetes mellitus

Yaomin Hu, Pamela J Kaisaki, Karène Argoud, Steven P Wilder, Karin J Wallace, Peng Y Woon, Christine Blancher, Lise Tarnow, Per-Henrik Groop, Samy Hadjadj, Michel Marre, Hans-Henrik Parving, Martin Fa

Journal:

BMC Medical Genomics

Year:

2009

Language:

english

File:

PDF, 1.19 MB

english, 2009

42

Myocardial perfusion in type 2 diabetes with left ventricular hypertrophy: normalisation by acute angiotensin-converting enzyme inhibition

Birger Hesse, Christian Meyer, FlemmingS. Nielsen, Asako Sato, JensD. Hove, Soeren Holm, LiaE. Bang, KlausF. Kofoed, TageL. Svendsen, Hans-Henrik Parving, LionelH. Opie

Journal:

European Journal of Nuclear Medicine and Molecular Imaging

Year:

2004

Language:

english

File:

PDF, 257 KB

english, 2004

43

Microalbuminuria in type 1 and type 2 diabetes mellitus: Evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy

Hans-Henrik Parving, Peter Hovind

Journal:

Current Hypertension Reports

Year:

2002

Language:

english

File:

PDF, 455 KB

english, 2002

44

Clinical trials report

Matthew R. Weir, Hans-Henrik Parving

Journal:

Current Hypertension Reports

Year:

2004

Language:

english

File:

PDF, 157 KB

english, 2004

45

Remission and regression of diabetic nephropathy

Peter Hovind, Lise Tarnow, Hans-Henrik Parving

Journal:

Current Hypertension Reports

Year:

2004

Language:

english

File:

PDF, 343 KB

english, 2004

46

Plasma and Interstitial Fluid Volume in Extensive Skin Disease.

Worm, Anne-Marie, Parving, Hans-Henrik

Journal:

The Journal of Investigative Dermatology

Year:

1981

File:

PDF, 1.18 MB

1981

47

Plasma volume, intravascular albumin and its transcapillary escape rate in patients with extensive skin disease

HANS-HENRIK PARVING, ANNE-MARIE WORM, NIELS ROSSING

Journal:

British Journal of Dermatology

Year:

1976

Language:

english

File:

PDF, 376 KB

english, 1976

48

Microalbuminuria and obesity: impact on cardiovascular disease and mortality

Klaus Peder Klausen, Hans-Henrik Parving, Henrik Scharling, Jan Skov Jensen

Journal:

Clinical Endocrinology

Year:

2009

Language:

english

File:

PDF, 367 KB

english, 2009

49

Prevention and treatment of diabetic nephropathy with blood pressure lowering drugs

HANS-HENRIK PARVING, PETER ROSSING, LISE TARNOW, EVA HOMMEL, ELISABETH MATHIESEN

Journal:

Year:

1996

Language:

english

File:

PDF, 318 KB

english, 1996

50

Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy

Jacobsen, Peter, Rossing, Kasper, Rossing, Peter, Tarnow, Lise, Mallet, Christine, Poirier, Odette, Cambien, Francois, Parving, Hans-Henrik

Journal:

Kidney International

Year:

1998

Language:

english

File:

PDF, 173 KB

english, 1998